Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To evaluate the efficacy of two doses of the adsorbed vaccine COVID-19 (inactivated) produced by Sinovac in symptomatic individuals, with virological confirmation of COVID-19, two weeks after the completion of the two-dose vaccination regimen, aged 18 years or older who work as health pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Palacios, Ricardo, Patiño, Elizabeth González, de Oliveira Piorelli, Roberta, Conde, Monica Tilli Reis Pessoa, Batista, Ana Paula, Zeng, Gang, Xin, Qianqian, Kallas, Esper G., Flores, Jorge, Ockenhouse, Christian F., Gast, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558252/
https://www.ncbi.nlm.nih.gov/pubmed/33059771
http://dx.doi.org/10.1186/s13063-020-04775-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558252/
https://www.ncbi.nlm.nih.gov/pubmed/33059771
http://dx.doi.org/10.1186/s13063-020-04775-4

Ejemplares similares